10.1523/JNEUROSCI.23-02-00550.2003 J
Mas recientemente los inhibidores del cotransportador sodio-glucosa tipo 2 han demostrado ofrecer proteccin cardiovascular y renal, pero el riesgo residual sigue siendo alto y su eficacia antihiperglucemiante es limitada en ERC moderada-severa
Designed around the GLP-1 hormone to help curb hunger and reduce emotional eating
Additionally, semaglutide should be used with caution in patients with a history of pancreatitis, gallbladder disease, or severe gastrointestinal disorders
Data / Specifications Compound Specifications 225 H 348 N 48 O 68 Synonyms HA-TRZ, LY3298176, Mounjaro compound Research Applications Context / Research Dual agonist targeting both GIP receptor (primary) and GLP-1 receptor (secondary)
(Source 1, 2) Glutathione levels decline with age and lower levels are associated with chronic diseases, including autoimmune diseases